| | Identification | Back Directory |  | [Name] 
 1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
 |  | [CAS] 
 1911644-32-0
 |  | [Synonyms] 
 Ruxolitinib-amide
 Ruxolitinib Impurity 5
 Ruxolitinib Impurity 6
 Ruxolitinib Impurity 25
 1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
 Ruxolitinib-amideQ: What is 
Ruxolitinib-amide Q: What is the CAS Number of 
Ruxolitinib-amide Q: What is the storage condition of 
Ruxolitinib-amide
 |  | [Molecular Formula] 
 C17H20N6O
 |  | [MOL File] 
 1911644-32-0.mol
 |  | [Molecular Weight] 
 324.39
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 216-217°C
 |  | [density ] 
 1.50±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 -20°C Freezer, Under inert atmosphere
 |  | [solubility ] 
 Ethyl Acetate (Slightly), Methanol (Slightly)
 |  | [form ] 
 Solid
 |  | [pka] 
 11.69±0.50(Predicted)
 |  | [color ] 
 White to Off-White
 |  | [Stability:] 
 Unstable in Solution
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Ruxolitinib-amide is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
 | 
 |  |